封面
市場調查報告書
商品編碼
2077203

瀉藥市場:依產品類型、劑型、通路和地區分類

Laxatives Market, By Product Type, By Form, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年瀉藥市值為51.1億美元,預計2033年將達到78.8億美元。預計從2026年到2033年,其複合年成長率將達到6.4%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 51.1億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.40% 2033年市場規模預測: 78.8億美元

全球瀉藥市場涵蓋多種產品類型,包括容積性瀉藥、刺激性瀉藥和滲透性瀉藥,並可用於口服和直腸給藥等多種途徑。醫院和零售藥局對瀉藥的需求不斷成長,以及對更有效率、更可靠解決方案的需求日益增加,推動了市場需求的發展。技術的持續進步和終端用戶需求的不斷成長,也進一步促進了該市場的成長。

市場動態:

口服和直腸給藥途徑的普及、終端用戶需求的成長以及對提高療效和性能的持續關注,預計將是推動全球瀉藥市場成長的主要因素。豐富的產品選擇也使得更多使用者能夠使用這些解決方案。

例如,各公司正在拓展產品線,以滿足醫院藥局和零售藥局不斷變化的需求。此外,預計在預測期內,加大創新投入和整合新技術將為市場參與者創造新的成長機會。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球瀉藥市場主要參與者的概況。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球瀉藥市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球瀉藥市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • 主要進展
  • PEST分析
  • 夥伴關係方案
  • 品牌和定價分析
  • 銷售代理情況
  • 波特的分析
  • 技術進步
  • 主要進展
  • 市場趨勢
  • 前景
  • 按銷售收入排名的主要公司

第4章 瀉藥市場:依產品類型分類,2026-2033年

  • 容積性瀉藥
  • 刺激性瀉藥
  • 滲透性瀉藥
  • 潤滑性瀉藥
  • 其他

第5章 瀉藥市場:依劑型分類,2026-2033年

  • 口服
  • 直腸
  • 其他

第6章 瀉藥市場:依通路分類,2026-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 其他

第7章 瀉藥市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 比荷盧經濟聯盟
    • 丹麥
    • 挪威
    • 瑞典
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 台灣
    • 印度
    • 日本
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 新加坡
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東和非洲
    • 巴林
    • 科威特
    • 阿曼
    • 卡達
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 北非
    • 中非
    • 其他中東國家

第8章 競爭情勢

  • Bayer AG
  • Pfizer Inc.
  • Sanofi SA
  • Johnson & Johnson Services, Inc.
  • Dr. Reddy's Laboratories
  • Takeda Pharmaceutical Company Limited
  • Mylan NV
  • Abbott Laboratories
  • Glenmark Pharmaceuticals Ltd.
  • Cipla Limited

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1052

Laxatives Market is estimated to be valued at USD 5.11 billion in 2026 and is expected to reach USD 7.88 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.11 billion
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.40% 2033 Value Projection: USD 7.88 billion

The global laxatives market covers a broad set of product type categories, including Bulk-forming laxatives, Stimulant laxatives, and Osmotic laxatives, used across applications such as Oral, and Rectal. Demand is supported by adoption among Hospital Pharmacies, and Retail Pharmacies and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Oral, and Rectal, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global laxatives market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Hospital Pharmacies, and Retail Pharmacies. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global laxatives market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Dr. Reddys Laboratories, Takeda Pharmaceutical Company Limited, Mylan N.V., Abbott Laboratories, Glenmark Pharmaceuticals Ltd., and Cipla Limited, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global laxatives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global laxatives market.

Detailed Segmentation:

  • Global Laxatives Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Bulk-forming laxatives
  • Stimulant laxatives
  • Osmotic laxatives
  • Lubricant laxatives
  • Others
  • Global Laxatives Market, By Form (Revenue, USD Bn, 2021 - 2033)
  • Oral
  • Rectal
  • Others
  • Global Laxatives Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Bayer AG*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Pfizer Inc.
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • Dr. Reddys Laboratories
  • Takeda Pharmaceutical Company Limited
  • Mylan N.V.
  • Abbott Laboratories
  • Glenmark Pharmaceuticals Ltd.
  • Cipla Limited

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Form
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Partnership Scenario
  • Brand and Pricing Analysis
  • Distributors Landscape
  • Porters Analysis
  • Technological Advancements
  • Key Developments
  • Market Trend
  • Future Prospective
  • Top Market Players by Revenue

4. Laxatives Market, By Product Type, 2026-2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Bulk-forming laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Stimulant laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Osmotic laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Lubricant laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Laxatives Market, By Form, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Laxatives Market, By Distribution Channel, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Laxatives Market, By Region, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Benelux
      • Denmark
      • Norway
      • Sweden
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • China
      • Taiwan
      • India
      • Japan
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • Bahrain
      • Kuwait
      • Oman
      • Qatar
      • Saudi Arabia
      • UAE
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of Middle East

8. Competitive Landscape

  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dr. Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Glenmark Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us